Old Web
English
Sign In
Acemap
>
authorDetail
>
Tae H. Han
Tae H. Han
Seattle Genetics
Brentuximab vedotin
Medicine
Antibody-drug conjugate
Pharmacokinetics
Monomethyl auristatin E
6
Papers
266
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
CYP Suppression in Human Hepatocytes by Monomethyl Auristatin E, the Payload in Brentuximab Vedotin (Adcetris®), is Associated with Microtubule Disruption
2018
European Journal of Drug Metabolism and Pharmacokinetics
Francis S. Wolenski
Cindy Q. Xia
Bingli Ma
Tae H. Han
Wen Chyi Shyu
Suresh K. Balani
Show All
Source
Cite
Save
Citations (6)
Effect Of Renal Impairment On The Pharmacokinetics Of Brentuximab Vedotin, An Antibody-drug Conjugate, In Patients With Cd30-positive Hematologic Malignancies.: pi-10
2013
Clinical Pharmacology & Therapeutics
Tae H. Han
L. E. Grove
C. M. Lynch
Show All
Source
Cite
Save
Citations (3)
CYP3A-mediated drug-drug interaction potential and excretion of brentuximab vedotin, an antibody-drug conjugate, in patients with CD30-positive hematologic malignancies.
2013
The Journal of Clinical Pharmacology
Tae H. Han
Ajay K. Gopal
Radhakrishnan Ramchandren
Andre Goy
Robert Chen
Jeffrey Matous
Maureen Cooper
Laurie E. Grove
Stephen C. Alley
Carmel M. Lynch
Owen A. OConnor
Show All
Source
Cite
Save
Citations (52)
1